-
1دورية أكاديمية
المؤلفون: Saara Huoponen, Kalle J Aaltonen, Jaana Viikinkoski, Jarno Rutanen, Heikki Relas, Kirsi Taimen, Kari Puolakka, Dan Nordström, Marja Blom
المصدر: PLoS ONE, Vol 14, Iss 7, p e0220142 (2019)
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1932-6203
-
2دورية أكاديمية
المؤلفون: Laura S M Kuula, Kati M Viljemaa, Janne T Backman, Marja Blom
المصدر: PLoS ONE, Vol 14, Iss 4, p e0216029 (2019)
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1932-6203
-
3دورية أكاديمية
المؤلفون: Saara Huoponen, Marja Blom
المصدر: PLoS ONE, Vol 10, Iss 12, p e0145087 (2015)
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1932-6203
-
4دورية أكاديمية
المؤلفون: Jaana T Joensuu, Saara Huoponen, Kalle J Aaltonen, Yrjö T Konttinen, Dan Nordström, Marja Blom
المصدر: PLoS ONE, Vol 10, Iss 3, p e0119683 (2015)
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1932-6203
-
5دورية أكاديمية
المؤلفون: Lianne Barnieh, Fiona Clement, Anthony Harris, Marja Blom, Cam Donaldson, Scott Klarenbach, Don Husereau, Diane Lorenzetti, Braden Manns
المصدر: PLoS ONE, Vol 9, Iss 3, p e90434 (2014)
وصف الملف: electronic resource
-
6دورية أكاديمية
المؤلفون: Kalle J Aaltonen, Liisa M Virkki, Antti Malmivaara, Yrjö T Konttinen, Dan C Nordström, Marja Blom
المصدر: PLoS ONE, Vol 7, Iss 1, p e30275 (2012)
وصف الملف: electronic resource
-
7
المؤلفون: Jukka Ronkainen, Raisa Laaksonen, Nelli Äijö-Jensen, Marjo Yliperttula, Marja Blom, Hanna Kortejärvi, Heini Kari
المساهمون: Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, Division of Pharmaceutical Biosciences, Drug Research Program, Biopharmaceutics Group, Divisions of Faculty of Pharmacy, Teachers' Academy, Clinical Pharmacy Group, Pharmacoeconomics
المصدر: Research in Social and Administrative Pharmacy. 18:3004-3012
مصطلحات موضوعية: medicine.medical_specialty, Community-living older people, Cost effectiveness, Cost-Benefit Analysis, people-centred care, Pharmacist, Pharmaceutical Science, Pharmacy, Clinically trained pharmacist, law.invention, Clinical medication review, 03 medical and health sciences, 0302 clinical medicine, PRIMARY CARE, Quality of life, Randomized controlled trial, law, Intervention (counseling), Health care, Humans, health outcomes, Medicine, 030212 general & internal medicine, cost-effectiveness, Aged, clinically trained pharmacist, business.industry, 030503 health policy & services, Health outcomes, Primary care, People-centred care, 317 Pharmacy, community-living, Usual care, Quality of Life, Physical therapy, Cost-effectiveness, Quality-Adjusted Life Years, Older people, 0305 other medical science, business
وصف الملف: application/pdf
-
8
المؤلفون: Laura S. M. Kuula, Marja Blom, Janne T. Backman
المساهمون: Division of Pharmacology and Pharmacotherapy, HUSLAB, Department of Clinical Pharmacology, Janne Backman / Principal Investigator, Clinicum, INDIVIDRUG - Individualized Drug Therapy, Divisions of Faculty of Pharmacy, Pharmacoeconomics
المصدر: Pharmacology Research & Perspectives
Pharmacology Research & Perspectives, Vol 9, Iss 3, Pp n/a-n/a (2021)مصطلحات موضوعية: medicine.medical_specialty, medicine.medical_treatment, Patient characteristics, costs, RM1-950, 030204 cardiovascular system & hematology, antibiotics, EVENTS, 03 medical and health sciences, Health services, Indirect costs, 0302 clinical medicine, Tendinitis, Tendon Injuries, medicine, Humans, 030212 general & internal medicine, General Pharmacology, Toxicology and Pharmaceutics, adverse drug reactions, Rehabilitation, business.industry, Retrospective cohort study, ADVERSE DRUG-REACTIONS, Original Articles, Patient Acceptance of Health Care, medicine.disease, Anti-Bacterial Agents, 3. Good health, Tendon, 3141 Health care science, medicine.anatomical_structure, Neurology, 317 Pharmacy, Emergency medicine, Original Article, Private healthcare, Therapeutics. Pharmacology, business, Fluoroquinolones, tendons
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da7c658a04b5eeb807b8318c512b3785
http://hdl.handle.net/10138/332739 -
9
المؤلفون: Dan Nordström, Heikki Relas, Kirsi Taimen, Marja Blom, Jarno Rutanen, Kalle Aaltonen, Kari Puolakka, Saara Huoponen, Jaana Viikinkoski
المساهمون: University of Helsinki, Division of Pharmacology and Pharmacotherapy, Divisions of Faculty of Pharmacy, HUS Inflammation Center, Reumatologian yksikkö, HUS Internal Medicine and Rehabilitation, University Management, Department of Medicine, Pharmacoeconomics
المصدر: PLoS ONE
PLoS ONE, Vol 14, Iss 7, p e0220142 (2019)مصطلحات موضوعية: Oncology, Male, European People, Cost effectiveness, Physiology, Economics, Cost-Benefit Analysis, Cancer Treatment, Arthritis, Social Sciences, Finnish People, Arthritis, Rheumatoid, chemistry.chemical_compound, Indirect costs, Biological Factors, 0302 clinical medicine, NECROSIS-FACTOR INHIBITOR, Immune Physiology, Outpatients, Medicine and Health Sciences, FAILURE, Ethnicities, 030212 general & internal medicine, health care economics and organizations, Finland, Innate Immune System, Multidisciplinary, Pharmaceutics, Simulation and Modeling, Middle Aged, COLLEGE-OF-RHEUMATOLOGY, 3. Good health, EULAR RECOMMENDATIONS, Treatment Outcome, 317 Pharmacy, Chemotherapy, Adjuvant, Rheumatoid arthritis, SAFETY, Antirheumatic Agents, Medicine, Cytokines, Rituximab, Female, Quality-Adjusted Life Years, medicine.drug, Research Article, musculoskeletal diseases, medicine.medical_specialty, Drug Administration, Patients, Science, Immunology, Cost-Effectiveness Analysis, Rheumatoid Arthritis, Research and Analysis Methods, Antibodies, Monoclonal, Humanized, VALIDATION, Drug Costs, Autoimmune Diseases, Abatacept, 03 medical and health sciences, Tocilizumab, Drug Therapy, Rheumatology, Internal medicine, medicine, MANAGEMENT, Humans, Adverse effect, 030203 arthritis & rheumatology, business.industry, Biology and Life Sciences, Molecular Development, medicine.disease, Economic Analysis, LIFE, Health Care, chemistry, 3121 General medicine, internal medicine and other clinical medicine, Immune System, People and Places, MODIFYING ANTIRHEUMATIC DRUGS, Clinical Immunology, Population Groupings, Tumor Necrosis Factor Inhibitors, Clinical Medicine, business, Developmental Biology
-
10
المؤلفون: Janne T. Backman, Laura S. M. Kuula, Marja Blom, Kati M. Viljemaa
المساهمون: Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, HUSLAB, Department of Clinical Pharmacology, Janne Backman / Principal Investigator, INDIVIDRUG - Individualized Drug Therapy, Faculty of Medicine, Medicum, Pharmacoeconomics
المصدر: PLoS ONE
PLoS ONE, Vol 14, Iss 4, p e0216029 (2019)
Pharmacology Research & Perspectivesمصطلحات موضوعية: medicine.medical_specialty, Science, MEDLINE, DRUG-REACTIONS, CINAHL, Disease, CIPROFLOXACIN, Cochrane Library, CLOSTRIDIUM-DIFFICILE, DISEASE, 03 medical and health sciences, SEVERE DYSGLYCEMIA, 0302 clinical medicine, Moxifloxacin, medicine, Humans, MOXIFLOXACIN, 030212 general & internal medicine, Adverse effect, Intensive care medicine, RISK, Multidisciplinary, business.industry, Publications, Health Care Costs, Health Services, 3. Good health, Systematic review, 317 Pharmacy, SAFETY, Commentary, Medicine, ACUTE LIVER-INJURY, Observational study, 3111 Biomedicine, BURDEN, business, 030217 neurology & neurosurgery, Facilities and Services Utilization, medicine.drug, Fluoroquinolones, Research Article
Full Text Finder